Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients. - Wikidata - wikimedia - TriplyDB

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

http://www.wikidata.org/entity/Q35558093

about

Expression of stem cell and epithelial-mesenchymal transition markers in circulating tumor cells of breast cancer patients The Significance of Epithelial-to-Mesenchymal Transition for Circulating Tumor Cells Minimal residual disease in breast cancer: an overview of circulating and disseminated tumour cells Epithelial-Mesenchymal Transition and Breast Cancer Single-cell analyses of circulating tumor cells Detection of circulating tumor cells Epithelial-mesenchymal plasticity in carcinoma metastasis The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment Epithelial-mesenchymal transition: focus on metastatic cascade, alternative splicing, non-coding RNAs and modulating compounds The emerging molecular machinery and therapeutic targets of metastasis Circulating tumour cells: the evolving concept and the inadequacy of their enrichment by EpCAM-based methodology for basic and clinical cancer research Dissecting the Heterogeneity of Circulating Tumor Cells in Metastatic Breast Cancer: Going Far Beyond the Needle in the Haystack Gene Expression and Proteome Analysis as Sources of Biomarkers in Basal Cell Carcinoma Stem-like plasticity and heterogeneity of circulating tumor cells: current status and prospect challenges in liver cancer EMT, CTCs and CSCs in tumor relapse and drug-resistance Using circulating tumor cells to inform on prostate cancer biology and clinical utility CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer Four amino acids within a tandem QxVx repeat in a predicted extended α-helix of the Smad-binding domain of Sip1 are necessary for binding to activated Smad proteins Mesothelin promotes epithelial-to-mesenchymal transition and tumorigenicity of human lung cancer and mesothelioma cells N-nitroso-N-ethylurea activates DNA damage surveillance pathways and induces transformation in mammalian cells.Towards the Biological Understanding of CTC: Capture Technologies, Definitions and Potential to Create Metastasis.PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells Olfactomedin-1 activity identifies a cell invasion checkpoint during epithelial-mesenchymal transition in the chick embryonic heart.RGC32 induces epithelial-mesenchymal transition by activating the Smad/Sip1 signaling pathway in CRC.Comparison of the PI3KCA pathway in circulating tumor cells and corresponding tumor tissue of patients with metastatic breast cancer.A novel flow cytometry-based cell capture platform for the detection, capture and molecular characterization of rare tumor cells in blood.ROS-induced epithelial-mesenchymal transition in mammary epithelial cells is mediated by NF-kB-dependent activation of Snail.Sensitive detection of viable circulating tumor cells using a novel conditionally telomerase-selective replicating adenovirus in non-small cell lung cancer patients Circulating tumor cells exhibit a biologically aggressive cancer phenotype accompanied by selective resistance to chemotherapy.Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition Circulating tumor cells: from bench to bedside EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer Prognostic significance of cyclin D1, β-catenin, and MTA1 in patients with invasive ductal carcinoma of the breast.Microsieve lab-chip device for rapid enumeration and fluorescence in situ hybridization of circulating tumor cells.Epithelial mesenchymal transition is required for acquisition of anoikis resistance and metastatic potential in adenoid cystic carcinoma Crosstalk of Oncogenic Signaling Pathways during Epithelial-Mesenchymal Transition.Evaluation of proliferation and apoptosis markers in circulating tumor cells of women with early breast cancer who are candidates for tumor dormancy.Circulating and disseminated tumor cells from breast cancer patient-derived xenograft-bearing mice as a novel model to study metastasis.

P2860

Q21284707-31F520D9-4F58-45B7-8894-EA24A79227A0 Q26741223-41B3EC3E-F662-42E5-9194-9EFE3AE02F72 Q26748850-4962D526-C9BA-4892-8267-7D714D5A4FAC Q26773055-F736AD16-6FFE-482C-850D-E5A79CACE7BB Q26778816-4C41FE72-942A-4FE7-922A-7C888EEC3D61 Q26859334-E2284A8E-C49C-4B52-BD62-8C997AFDC493 Q26859804-41734D26-C535-484E-B4EF-F404B8BC51C0 Q26865458-A906AFDA-5719-457E-B039-A2FE15AAF3C8 Q27013565-EAFAC8B6-F829-4101-9FFE-AC6CBC0A996E Q27022207-56EC9389-AE17-4572-8031-2B20AB657B37 Q27024191-2BA184D6-21CA-4796-B430-C53AE209E956 Q28067549-731BA77E-BDD8-47DC-B46D-5DA422362C8F Q28074335-9DEADFD0-D75C-4A97-97CD-D2DC9724538C Q28079205-1E5CCFD5-6941-4567-A030-754AD941A0F2 Q28082935-4AC8662C-0809-414D-AEF7-D9369045D3F2 Q28083261-3BD2F422-2514-4C58-8421-A6957AEF5A30 Q28250164-39880D6F-B752-40DC-B40C-A329F30962F9 Q28387216-9563257A-92FF-4F54-8C24-E477F94629DA Q28534349-2A03E233-3868-4878-AB29-648846F4854B Q29048401-E75A6FE9-A0CA-4DDB-AB26-F8CC65E8000F Q30413046-4F810EE0-1CFF-4D98-84C2-1802BE052616 Q30445250-42B83C17-5CF6-441C-A107-BF1AD7763D82 Q30536377-0C2CD492-D3CC-4444-9776-35BC817F535F Q30539142-8C0869FC-96E0-4A60-8EEE-FCA1C0320F98 Q33634647-65CC582A-F1F4-4653-8FF3-C901D2F2886B Q33674656-7A8288A1-996F-43A9-A3E2-FF52589A2BAE Q33741201-1356F0C3-1C5D-41F6-9E90-2E5EC5D15F6C Q33757116-3E1F1A15-878C-4EC2-97B6-A2388C2F0B66 Q33798634-661F656A-E188-4FD6-AAA9-E131168B0E78 Q34069988-45E37316-3DFC-4481-BA76-25A1C93252D9 Q34168398-017DD9D3-4082-45E5-B555-3447DDAE641B Q34271512-0701422A-DC4D-449D-842A-3655E3B7FAD8 Q34307782-A7FF9F18-75BA-4EDA-AA5E-942A259E9044 Q34365738-A23CF2B5-D10F-46DD-9629-3B0BFE82A268 Q34366636-F49F1893-9DA7-4BD8-9CA5-A98881F9A8F8 Q34396921-989EBE22-4483-44D5-91B7-D15CE9570B35 Q34525327-4545FD46-BEDB-4105-95FE-2D6F5EF5F79D Q34677454-B5A1654C-04A3-4C17-99AC-B2A28C3DFEA2 Q35000713-CFEACA51-D8A4-43B6-93E8-7BE7FC547E88 Q35053624-0DC732A9-929B-4F34-AC52-366BEA8FF60A

P2860

Epithelial to mesenchymal transition markers expressed in circulating tumour cells of early and metastatic breast cancer patients.

http://www.wikidata.org/entity/Q35558093

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Epithelial to mesenchymal tran ...... static breast cancer patients.

@ast

Epithelial to mesenchymal tran ...... static breast cancer patients.

@en

type

label

Epithelial to mesenchymal tran ...... static breast cancer patients.

@ast

Epithelial to mesenchymal tran ...... static breast cancer patients.

@en

prefLabel

Epithelial to mesenchymal tran ...... static breast cancer patients.

@ast

Epithelial to mesenchymal tran ...... static breast cancer patients.

@en

P1433

Q35558093-A682FC7E-450D-4976-85EF-91EECFA72161

P1476

Q35558093-D96BE230-F9FB-4D6B-B2F9-B82D33A8B665

P2093

Q35558093-1610141C-0A6C-4A6B-A8C2-3EB7CE1DC281

Q35558093-2864EB7C-3B05-465C-9820-BCE555C79346

Q35558093-539EF505-314A-46D5-B24D-730FE0BB8070

Q35558093-5A429C76-A221-461C-AC44-F745140EDA28

Q35558093-C3A9B297-C1A8-4357-BF68-AE08CB222971

P2860

Q35558093-0C000C63-C776-46B0-A712-4966D894AAA8

Q35558093-1679957C-A9C0-4AD0-8944-2A1CE6DE75B7

Q35558093-1E715C80-5143-43B9-996E-8D1DF8C4CD5C

Q35558093-216A9517-B204-4986-9DCF-80934D130D2F

Q35558093-27225798-3BB1-4B99-BC64-EFCB927A6242

Q35558093-28591DA2-39AF-4256-B335-A9147237EC22

Q35558093-29D140BF-DB35-4D8D-A5DD-E65F5CDE3D5A

Q35558093-3300CCA5-49BE-4707-A946-724B4477DCCD

Q35558093-34D9356F-062D-42D8-819C-BF0AEE9EC799

Q35558093-41E9536E-76C7-4D67-BF95-33569F360173

P2888

Q35558093-11ECA4D2-1E76-46C5-8AF3-AF9C3777B198

P304

Q35558093-BBEC5F83-FACB-4A72-A57E-EA791C6DACCC

P31

Q35558093-3EA5D06B-4BC2-4A70-B82A-4C4A59A877AC

P356

Q35558093-51EF95DD-1100-44B8-B72D-0C33B925AAAD

P433

Q35558093-6D8D2A23-BCAB-4224-8B14-DD3E1939612A

P478

Q35558093-AE6A586E-EAA1-42B9-B011-A2FAC3F21094

P50

Q35558093-B5BBA694-21F7-44A7-B41C-6F0800E47C43

P577

Q35558093-4EBF0057-21C1-4CE4-BA48-813DEB10E24C

P5875

Q35558093-24506B0D-0B96-4892-9264-1D42A0CCA71A

P6179

Q35558093-E94F46B4-40C0-4B95-A87B-39888247144B

P698

Q35558093-81AF70F6-9FD9-4DB5-BE78-352EDD3DB12D

P932

Q35558093-A2A6EC38-7293-470E-8DCA-59B641ACD845

P356

P1433

Breast Cancer Research

P1476

Epithelial to mesenchymal tran ...... astatic breast cancer patients

@en

P2093

Dimitris Mavroudis

http://www.w3.org/2001/XMLSchema#string

Eleni Politaki

http://www.w3.org/2001/XMLSchema#string

Maria A Papadaki

http://www.w3.org/2001/XMLSchema#string

Sophia Agelaki

http://www.w3.org/2001/XMLSchema#string

Vassilis Georgoulias

http://www.w3.org/2001/XMLSchema#string

P2860

Twist transcriptionally up-regulates AKT2 in breast cancer cells leading to increased migration, invasion, and resistance to paclitaxel

Direct regulation of TWIST by HIF-1alpha promotes metastasis

Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis

Aberrant expression of the tyrosine kinase receptor EphA4 and the transcription factor twist in Sézary syndrome identified by gene expression analysis

The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression

Circulating tumor cells, disease progression, and survival in metastatic breast cancer

Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells.

Hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression in circulating tumor cells of breast cancer patients.

Phosphorylation of FAK, PI-3K, and impaired actin organization in CK-positive micrometastatic breast cancer cells

Cadherins and catenins: role in signal transduction and tumor progression.

P2888

P304

R59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2896

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

Galatea Kallergi

P577

2011-06-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51210031

http://www.w3.org/2001/XMLSchema#string

P6179

1025068252

http://www.w3.org/2001/XMLSchema#string

P698

21663619

http://www.w3.org/2001/XMLSchema#string

P932

3218948

http://www.w3.org/2001/XMLSchema#string